NCT05822128

Brief Summary

The Epworth Sleepiness Scale (ESS) is undoubtedly the most commonly used tool in daily clinical practice to assess daytime sleepiness in patients of all ages by means of a self-administered questionnaire. In elderly subjects, the clinician is often confronted with difficulties in accurately estimating the ESS score and measuring subjective daytime sleepiness. Indeed, according to Onen et al, the ESS tends to underestimate the prevalence of sleep disorders in the geriatric population, mainly due to non-response to problematic items, namely:

  • Item 3: Sitting, inactive in a public place (cinema, theater, meeting)
  • Item 8: In a car that has been stopped for a few minutes. In order to overcome this problem, Janine Gronewold's German team has developed and begun work on the validation of an alternative version of the ESS, the ESS-ALT, adapted to the population of interest, in German. The aim of the present work is to adapt the ESS-ALT in French, then to study its correlation with sleep data recorded by nocturnal polysomnography, and among the secondary objectives, to correlate it with sleep latency during iterative sleep latency tests, in order to propose to the clinician a simple, reproducible tool, allowing to measure daytime sleepiness in elderly subjects.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
102

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Jun 2023

Shorter than P25 for all trials

Geographic Reach
1 country

2 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 27, 2023

Completed
24 days until next milestone

First Posted

Study publicly available on registry

April 20, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 28, 2023

Completed
4 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 19, 2023

Completed
1 day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 20, 2023

Completed
Last Updated

November 27, 2023

Status Verified

November 1, 2023

Enrollment Period

4 months

First QC Date

March 27, 2023

Last Update Submit

November 23, 2023

Conditions

Keywords

Excessive daytime sleepinessElderlyEpworth Sleepiness Scale

Outcome Measures

Primary Outcomes (1)

  • Validation of the alternative Epworth Daytime Sleepiness Scale -ALT adapted to the elderly and geriatric population in French

    forward and backward translation" between English and French, and correlation with the ESS sleepiness scale.

    24 hours

Secondary Outcomes (4)

  • Study of the correlation between the results of the French ESS-ALT and polysomnography data

    24 hours

  • Study of the correlation between the results of the French ESS-ALT and MSLT (Multiple Sleep Latency Test) data

    24 hours

  • intrinsic validity of the ESS-ALT in French

    24 months

  • Study of the correlation between the ESS-ALT cohort in French and the ESS-ALT cohort in Germany

    24 months

Study Arms (1)

Seniors with suspected sleep disorders referred for assessment

Seniors with suspected sleep disorders referred for assessment

Other: Test of an alternative Epworth Sleepiness Scale ESS-ALT in French

Interventions

Seniors recruited into the study will test the Epworth Alternate Sleepiness Scale -ALT

Seniors with suspected sleep disorders referred for assessment

Eligibility Criteria

Age65 Years+
Sexall
Healthy VolunteersNo
Age GroupsOlder Adult (65+)
Sampling MethodProbability Sample
Study Population

Seniors with suspected sleep disorders referred for assessment

You may qualify if:

  • Patient 65 years of age and older
  • Consulting for sleep disorders
  • Enrolled in a social security system or entitled to it
  • Patient informed and having expressed his non-opposition to participate in the research

You may not qualify if:

  • Severe psychiatric or cognitive disorders that do not allow the completion of examinations/questionnaires
  • Patients who are dependent for all acts of daily life
  • Patients with a very short life expectancy
  • Patients under guardianship or curatorship
  • Patients under AME
  • Patients whose first language is not French
  • Patients with visual or cognitive impairments that make reading impossible

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Hospital Charles Foix

Ivry-sur-Seine, 94205, France

Location

service des pathologies du sommeil, hôpital Pitié Salpêtrière

Paris, 75013, France

Location

MeSH Terms

Conditions

Disorders of Excessive Somnolence

Condition Hierarchy (Ancestors)

Sleep Disorders, IntrinsicDyssomniasSleep Wake DisordersNervous System DiseasesMental Disorders

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

March 27, 2023

First Posted

April 20, 2023

Study Start

June 28, 2023

Primary Completion

October 19, 2023

Study Completion

October 20, 2023

Last Updated

November 27, 2023

Record last verified: 2023-11

Locations